Reid index
Reid Index is a medical measurement used primarily in the field of pulmonology to quantify the extent of chronic bronchitis in histological lung samples. Named after the British pathologist, James Reid, who first described it in 1956, the Reid Index is a ratio that compares the thickness of the mucous gland layer to the thickness of the wall between the epithelium and the cartilage in the bronchus.
Calculation[edit]
The Reid Index is calculated by measuring the thickness of the mucous gland layer (d) and the thickness of the wall between the epithelium and the cartilage (h). The formula for the Reid Index is d/h. The normal value for the Reid Index is less than 0.4. A Reid Index of greater than 0.4 is indicative of chronic bronchitis.
Clinical Significance[edit]
The Reid Index is used in the diagnosis of chronic bronchitis. Chronic bronchitis is a type of chronic obstructive pulmonary disease (COPD) characterized by a long-term cough with mucus. The Reid Index helps to quantify the extent of the disease and can be used to monitor the progression of the disease over time.
Limitations[edit]
While the Reid Index is a useful tool in the diagnosis and monitoring of chronic bronchitis, it has its limitations. The measurement is dependent on the quality of the histological sample and the accuracy of the measurements. Additionally, the Reid Index does not take into account other factors that may contribute to the symptoms of chronic bronchitis, such as inflammation or infection.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian